Drawing for STANLEY

USPTO serial 75278270

STANLEY

Reviewed by CopyMark Law Group

Reg. 2261940Status 710
Filing date
Status date
Registration date
Jul 20, 1999
Examiner
JENKINS JR, CHARLES L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with STANLEY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RAUER L MEYER

RAUER L MEYER THELEN MARRIN JOHNSON & BRIDGES LLP2 EMBARCADERO CTRSAN FRANCISCO, CA 94111-3995UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001effervescent artificial sweetening agent in tablet and powder formSECTION 8 - CANCELLED—
005analgesics, namely, acetaminophen, acetylsalicylic acid, enteric coated acetylsalicylic acid, ibuprofen, acetaminophen, caffeine and codeine preparations, analgesic balm for topical application; cold and decongestant preparations, namely, medication for colds, hay fever and allergies; narcotics and controlled drugs, namely, codeine linctus, codeine phosphate syrup, cough syrup with codeine, opium tincture, phenobarbital, terpin hydrate and codeine elixir; medicated skin preparations, namely, hydrocortisone cream, medicated ointment for the treatment of ringworm of the scalp, medicated ointment for the treatment of skin irritation of the buttocks, perineal skin cleanser, perineal protection ointment, cold sore ointment and eczema ointment; pharmaceutical preparations, namely, aminophylline, chloral hydrate, folic acid, quinidine sulfate, quinine sulfate, sulfadiazine, ferrous gluconate, ferrous sulfate, namely, an astringent salt used as a tonic in medication, glutamic acid used in hydrochloric capsules for use as a gastric acidifier; specialized hospital products, namely, chlorhexidine gluconate solution used in calcium vitamins and mineral vitamins, docusate solution, docusate sodium preparations used as a stool softener, docusate sodium solution used as a stool softener, iodine used as an antiseptic and rubefacient, oral citrate solution; vitamin and mineral supplements; first aid products, namely, rubbing alcohol compound, alum powder, boric acid powder for use as an antiseptic, calamine lotion, camphor spirit used as an analgesic, camphorated oil, castor oil, citric acid powder used in cough syrups, acetaminophen syrups and as an acidifying agent, clove oil used as an analgesic, epsom salts, eucalyptus oil used as an antiseptic, balsam solution, namely, friar's balsam for use as an inhalant for bronchitis and as a local application for small fissures, glucose used in herbal vitamins, glycerin used in cough syrup preparations and in preparations for use in capsules, gelatin capsules and lotions, green soap tincture, hydrogen peroxide solution used as an antiseptic, hydrophillic petrolatum used as a water absorbable ointment base, iodine solution used as an antiseptic, isopropanol used as a topical antiseptic, isopropyl rubbing alcohol, lanolin used in zinc creams and analgesic cream preparations, merbromin, liquid petrolatum mineral oil used in vaginal ovules, as light body rub and for constipation relief, peppermint essence used as flavoring in lozenges and antacid products and the like, liniment, sodium bicarbonate tablets used for heartburn relief, sulfur ointment, distilled water, wintergreen oil for use as a flavoring in first aid products, witch hazel distilled extract, zinc oxide ointment for use in treating skin disorders; anti-diarrheal medication; laxative medication, antacid medication; anti-nausea and vomiting preparationsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2006C8..CANCELLED SEC. 8 (6-YR)—
Jul 20, 1999R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 7, 19991.BDSec. 1(B) CLAIM DELETED—
Jun 7, 1999IUCNNOTICE OF ALLOWANCE CANCELLED—
May 4, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 10, 1998ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 27, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 1998NPUBNOTICE OF PUBLICATION—
Aug 5, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance